Literature DB >> 17491064

Recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

V V Kalaja.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17491064     DOI： 10.1093/annonc/mdm016

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.

Authors:  Sayyed Farshid Moussavi-Harami; Kari B Wisinski; David J Beebe
Journal:  J Patient Cent Res Rev       Date:  2014

Review 2.  Trastuzumab : in HER2 and hormone receptor co-positive metastatic breast cancer.

Authors:  Jennifer S Orman; Caroline M Perry
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Different types of tumor vessels in breast cancer: morphology and clinical value.

Authors:  Marina A Senchukova; Natalia V Nikitenko; Olesia N Tomchuk; Nikon V Zaitsev; Alexander A Stadnikov
Journal:  Springerplus       Date:  2015-09-17

4.  Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer.

Authors:  Bella Kaufman; Steven Stein; Michelle A Casey; Beth O Newstat
Journal:  Biologics       Date:  2008-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.